Insulet Corp. buy BiotechBee
Start price
08.09.24
/
70%
€196.45
Target price
31.03.27
€230.00
Performance (%)
29.75%
End price
14.12.24
€254.90
Summary
This prediction ended on 14.12.24 with a price of €254.90. The BUY prediction by BiotechBee finished with a performance of 29.75%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insulet Corp. | -4.398% | -4.398% | -28.626% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% |
According to BiotechBee what are the pros and cons of Insulet Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Insulet Corp. diskutieren
Buy mit Kursziel 230,0